Novel immunomodulatory approaches for the management of multiple sclerosis.
about
Effects of chalcone derivatives on players of the immune systemCladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear CellsComparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database.A common gene expression signature in Huntington's disease patient brain regions.Increasing Incidence in Relapsing-Remitting MS and High Rates among Young Women in Finland: A Thirty-Year Follow-Up.Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis Progression.The promyelinating properties of androstenediol in gliotoxin-induced demyelination in rat corpus callosum.Molecular insights provide the critical path to disease mitigation.Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data.An Assay that Predicts In Vivo Efficacy for DNA Aptamers that Stimulate Remyelination in a Mouse Model of Multiple Sclerosis.
P2860
Q26796454-63252E2C-36CC-4981-AD9B-DE4394D8EC36Q28548449-7C47E8C0-D43D-4BEA-953D-9FE62C901B9AQ33736215-31C361C3-6553-4BDA-A69F-2E291A5C4263Q34446889-27739605-B4F3-4015-A207-2EB6EE6618BBQ34561939-E48427DA-AB14-47FC-9F3F-6A061CFC02B2Q35884067-356D7959-DA86-4D61-963C-6BC10262D004Q35921568-508B8DEE-EF98-4409-BA5B-15A1E9DA9D63Q38769752-FB870B55-620A-4C23-B480-6C65516E54AAQ41197337-F259D1E1-EEC1-4D52-B2D6-054E2BBE8288Q48384103-9BFFF2C6-2E42-4535-8E9A-53FF03BAF8C7Q49720568-4E2543D8-1B4E-491A-AE3B-6C718BF55A36Q54225482-263D9094-21C2-4F34-8DFB-4098690AD483
P2860
Novel immunomodulatory approaches for the management of multiple sclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel immunomodulatory approaches for the management of multiple sclerosis.
@en
type
label
Novel immunomodulatory approaches for the management of multiple sclerosis.
@en
prefLabel
Novel immunomodulatory approaches for the management of multiple sclerosis.
@en
P2860
P356
P1476
Novel immunomodulatory approaches for the management of multiple sclerosis.
@en
P2093
P2860
P356
10.1038/CLPT.2013.196
P407
P577
2013-10-30T00:00:00Z